(Q31881373)

4 July 2017

1 reference

title

Approaches to healing and prophylaxis of nonsteroidal anti-inflammatory drug-associated ulcers (English)

1 reference

4 July 2017

Yeomans ND

1

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

American Journal of Medicine

4 July 2017

published in

1 reference

4 July 2017

volume

110

1 reference

4 July 2017

issue

1A

1 reference

4 July 2017

page(s)

24S-28S

1 reference

Nonsteroidal anti-inflammatory drugs: overused or underused in osteoarthritis?

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Cyclooxygenase-2: a major therapeutic advance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Cyclooxygenase-2--specific inhibitors: are they safe?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Variability in risk of gastrointestinal complications with different nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Prophylactic aspirin and risk of peptic ulcer bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Electron microscopic study of the repair of aspirin-induced gastric erosions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Enhanced gastric mucosal bleeding with doses of aspirin used for prophylaxis and its reduction by ranitidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Misoprostol coadministered with diclofenac for prevention of gastroduodenal ulcers. A one-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

A double-blind comparison of the gastroduodenal safety and efficacy of diclofenac and a fixed dose combination of diclofenac and misoprostol in the treatment of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Cimetidine for peptic ulcer in patients with arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

The influence of cimetidine on peptic ulcer in patients with arthritis taking anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Peptic ulcer in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Prophylactic and therapeutic role of rioprostil in NSAIDs induced gastroduodenal lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

Non-steroidal anti-inflammatory drug associated ulcer: Epidemiology, causation and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900632-X

10.1016/S0002-9343(00)00632-X

7 January 2021

Identifiers

DOI

1 reference

4 July 2017

1 reference